Efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer: An open-label randomized active-controlled phase II clinical study (GOG-3044)

Journal article

Peer reviewed

Thomas Herzog, David O'Malley, John Liao, Karen Finkelstein, Lyndsay Willmott, John Moroney, Joseph Buscema, Katie Campbell-Simms and Susan Zweizig

Gynecologic oncology, Vol.200, p.8

09/2025

Metrics

3 Record Views

Title: Efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer: An open-label randomized active-controlled phase II clinical study (GOG-3044)
Creators: Thomas Herzog
David O'Malley
John Liao
Karen Finkelstein
Lyndsay Willmott
John Moroney
Joseph Buscema
Katie Campbell-Simms
Susan Zweizig
Publication Details: Gynecologic oncology, Vol.200, p.8
Identifiers: 991006226263702656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article